Multisite multiomic analysis reveals diverse resistance mechanisms in end-stage ovarian cancer

An international team led by researchers from MacCallum Cancer Center in Melbourne, Australia, examined 391 tumor tissues from about 270 multisite autopsy samples collected from 15 individuals with end-stage high-grade serous ovarian cancer (HGSC). All of the provided autopsy samples came from patients who had initially responded to their cancer treatment therapies but had become resistant to them in relapse.

source https://medicalxpress.com/news/2023-03-multisite-multiomic-analysis-reveals-diverse.html